0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Gene Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-13C13054
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Gene Therapy Sales Market Report 2023
BUY CHAPTERS

Gene Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-13C13054
Report
March 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Therapy - Market Size

The global market for Gene Therapy was estimated to be worth US$ 7077.6 million in 2023 and is forecast to a readjusted size of US$ 39700 million by 2030 with a CAGR of 27.6% during the forecast period 2024-2030

Gene Therapy - Market

Gene Therapy - Market

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.
In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Gene Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Gene Therapy by region & country, by Type, and by Application.
The Gene Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy.
Market Segmentation

Scope of Gene Therapy - Market Report

Report Metric Details
Report Name Gene Therapy - Market
Forecasted market size in 2030 US$ 39700 million
CAGR 27.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Viral Gene Therapy
  • Non-Viral Gene Therapy
Segment by Application
  • Neurological Diseases
  • Cancer
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Gene Therapy manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Gene Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Gene Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Gene Therapy - Market size in 2030?

Ans: The Gene Therapy - Market size in 2030 will be US$ 39700 million.

What is the market share of major companies in Gene Therapy - Market?

Ans: Global top three manufacturers hold a share about 75%.

Who are the main players in the Gene Therapy - Market report?

Ans: The main players in the Gene Therapy - Market are Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute

What are the Application segmentation covered in the Gene Therapy - Market report?

Ans: The Applications covered in the Gene Therapy - Market report are Neurological Diseases, Cancer, Other

What are the Type segmentation covered in the Gene Therapy - Market report?

Ans: The Types covered in the Gene Therapy - Market report are Viral Gene Therapy, Non-Viral Gene Therapy

1 Market Overview
1.1 Gene Therapy Product Introduction
1.2 Global Gene Therapy Market Size Forecast
1.3 Gene Therapy Market Trends & Drivers
1.3.1 Gene Therapy Industry Trends
1.3.2 Gene Therapy Market Drivers & Opportunity
1.3.3 Gene Therapy Market Challenges
1.3.4 Gene Therapy Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Gene Therapy Players Revenue Ranking (2023)
2.2 Global Gene Therapy Revenue by Company (2019-2024)
2.3 Key Companies Gene Therapy Manufacturing Base Distribution and Headquarters
2.4 Key Companies Gene Therapy Product Offered
2.5 Key Companies Time to Begin Mass Production of Gene Therapy
2.6 Gene Therapy Market Competitive Analysis
2.6.1 Gene Therapy Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Gene Therapy Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Viral Gene Therapy
3.1.2 Non-Viral Gene Therapy
3.2 Global Gene Therapy Sales Value by Type
3.2.1 Global Gene Therapy Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Gene Therapy Sales Value, by Type (2019-2030)
3.2.3 Global Gene Therapy Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Neurological Diseases
4.1.2 Cancer
4.1.3 Other
4.2 Global Gene Therapy Sales Value by Application
4.2.1 Global Gene Therapy Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Gene Therapy Sales Value, by Application (2019-2030)
4.2.3 Global Gene Therapy Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Gene Therapy Sales Value by Region
5.1.1 Global Gene Therapy Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Gene Therapy Sales Value by Region (2019-2024)
5.1.3 Global Gene Therapy Sales Value by Region (2025-2030)
5.1.4 Global Gene Therapy Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Gene Therapy Sales Value, 2019-2030
5.2.2 North America Gene Therapy Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Gene Therapy Sales Value, 2019-2030
5.3.2 Europe Gene Therapy Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Gene Therapy Sales Value, 2019-2030
5.4.2 Asia Pacific Gene Therapy Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Gene Therapy Sales Value, 2019-2030
5.5.2 South America Gene Therapy Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Gene Therapy Sales Value, 2019-2030
5.6.2 Middle East & Africa Gene Therapy Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Gene Therapy Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Gene Therapy Sales Value
6.3 United States
6.3.1 United States Gene Therapy Sales Value, 2019-2030
6.3.2 United States Gene Therapy Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Gene Therapy Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Gene Therapy Sales Value, 2019-2030
6.4.2 Europe Gene Therapy Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Gene Therapy Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Gene Therapy Sales Value, 2019-2030
6.5.2 China Gene Therapy Sales Value by Type (%), 2023 VS 2030
6.5.3 China Gene Therapy Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Gene Therapy Sales Value, 2019-2030
6.6.2 Japan Gene Therapy Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Gene Therapy Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Gene Therapy Sales Value, 2019-2030
6.7.2 South Korea Gene Therapy Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Gene Therapy Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Gene Therapy Sales Value, 2019-2030
6.8.2 Southeast Asia Gene Therapy Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Gene Therapy Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Gene Therapy Sales Value, 2019-2030
6.9.2 India Gene Therapy Sales Value by Type (%), 2023 VS 2030
6.9.3 India Gene Therapy Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biogen
7.1.1 Biogen Profile
7.1.2 Biogen Main Business
7.1.3 Biogen Gene Therapy Products, Services and Solutions
7.1.4 Biogen Gene Therapy Revenue (US$ Million) & (2019-2024)
7.1.5 Biogen Recent Developments
7.2 Novartis
7.2.1 Novartis Profile
7.2.2 Novartis Main Business
7.2.3 Novartis Gene Therapy Products, Services and Solutions
7.2.4 Novartis Gene Therapy Revenue (US$ Million) & (2019-2024)
7.2.5 Novartis Recent Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Profile
7.3.2 Gilead Sciences Main Business
7.3.3 Gilead Sciences Gene Therapy Products, Services and Solutions
7.3.4 Gilead Sciences Gene Therapy Revenue (US$ Million) & (2019-2024)
7.3.5 Sarepta Therapeutics Recent Developments
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Profile
7.4.2 Sarepta Therapeutics Main Business
7.4.3 Sarepta Therapeutics Gene Therapy Products, Services and Solutions
7.4.4 Sarepta Therapeutics Gene Therapy Revenue (US$ Million) & (2019-2024)
7.4.5 Sarepta Therapeutics Recent Developments
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Profile
7.5.2 Alnylam Pharmaceuticals Main Business
7.5.3 Alnylam Pharmaceuticals Gene Therapy Products, Services and Solutions
7.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue (US$ Million) & (2019-2024)
7.5.5 Alnylam Pharmaceuticals Recent Developments
7.6 Amgen
7.6.1 Amgen Profile
7.6.2 Amgen Main Business
7.6.3 Amgen Gene Therapy Products, Services and Solutions
7.6.4 Amgen Gene Therapy Revenue (US$ Million) & (2019-2024)
7.6.5 Amgen Recent Developments
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Profile
7.7.2 Spark Therapeutics Main Business
7.7.3 Spark Therapeutics Gene Therapy Products, Services and Solutions
7.7.4 Spark Therapeutics Gene Therapy Revenue (US$ Million) & (2019-2024)
7.7.5 Spark Therapeutics Recent Developments
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Profile
7.8.2 Akcea Therapeutics Main Business
7.8.3 Akcea Therapeutics Gene Therapy Products, Services and Solutions
7.8.4 Akcea Therapeutics Gene Therapy Revenue (US$ Million) & (2019-2024)
7.8.5 Akcea Therapeutics Recent Developments
7.9 bluebird bio
7.9.1 bluebird bio Profile
7.9.2 bluebird bio Main Business
7.9.3 bluebird bio Gene Therapy Products, Services and Solutions
7.9.4 bluebird bio Gene Therapy Revenue (US$ Million) & (2019-2024)
7.9.5 bluebird bio Recent Developments
7.10 Sunway Biotech
7.10.1 Sunway Biotech Profile
7.10.2 Sunway Biotech Main Business
7.10.3 Sunway Biotech Gene Therapy Products, Services and Solutions
7.10.4 Sunway Biotech Gene Therapy Revenue (US$ Million) & (2019-2024)
7.10.5 Sunway Biotech Recent Developments
7.11 SIBIONO
7.11.1 SIBIONO Profile
7.11.2 SIBIONO Main Business
7.11.3 SIBIONO Gene Therapy Products, Services and Solutions
7.11.4 SIBIONO Gene Therapy Revenue (US$ Million) & (2019-2024)
7.11.5 SIBIONO Recent Developments
7.12 AnGes
7.12.1 AnGes Profile
7.12.2 AnGes Main Business
7.12.3 AnGes Gene Therapy Products, Services and Solutions
7.12.4 AnGes Gene Therapy Revenue (US$ Million) & (2019-2024)
7.12.5 AnGes Recent Developments
7.13 Orchard Therapeutics
7.13.1 Orchard Therapeutics Profile
7.13.2 Orchard Therapeutics Main Business
7.13.3 Orchard Therapeutics Gene Therapy Products, Services and Solutions
7.13.4 Orchard Therapeutics Gene Therapy Revenue (US$ Million) & (2019-2024)
7.13.5 Orchard Therapeutics Recent Developments
7.14 Human Stem Cells Institute
7.14.1 Human Stem Cells Institute Profile
7.14.2 Human Stem Cells Institute Main Business
7.14.3 Human Stem Cells Institute Gene Therapy Products, Services and Solutions
7.14.4 Human Stem Cells Institute Gene Therapy Revenue (US$ Million) & (2019-2024)
7.14.5 Human Stem Cells Institute Recent Developments
8 Industry Chain Analysis
8.1 Gene Therapy Industrial Chain
8.2 Gene Therapy Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Gene Therapy Sales Model
8.5.2 Sales Channel
8.5.3 Gene Therapy Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Gene Therapy Market Trends
    Table 2. Gene Therapy Market Drivers & Opportunity
    Table 3. Gene Therapy Market Challenges
    Table 4. Gene Therapy Market Restraints
    Table 5. Global Gene Therapy Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Gene Therapy Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Gene Therapy Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Gene Therapy Product Type
    Table 9. Key Companies Time to Begin Mass Production of Gene Therapy
    Table 10. Global Gene Therapy Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Gene Therapy Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Gene Therapy Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Gene Therapy Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Gene Therapy Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Gene Therapy Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Gene Therapy Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Gene Therapy Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Gene Therapy Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Gene Therapy Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Gene Therapy Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Gene Therapy Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Gene Therapy Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Gene Therapy Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Gene Therapy Sales Value by Region (2019-2024) & (%)
    Table 27. Global Gene Therapy Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Gene Therapy Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Gene Therapy Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Gene Therapy Sales Value, (2025-2030) & (US$ Million)
    Table 31. Biogen Basic Information List
    Table 32. Biogen Description and Business Overview
    Table 33. Biogen Gene Therapy Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Gene Therapy Business of Biogen (2019-2024)
    Table 35. Biogen Recent Developments
    Table 36. Novartis Basic Information List
    Table 37. Novartis Description and Business Overview
    Table 38. Novartis Gene Therapy Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Gene Therapy Business of Novartis (2019-2024)
    Table 40. Novartis Recent Developments
    Table 41. Gilead Sciences Basic Information List
    Table 42. Gilead Sciences Description and Business Overview
    Table 43. Gilead Sciences Gene Therapy Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Gene Therapy Business of Gilead Sciences (2019-2024)
    Table 45. Gilead Sciences Recent Developments
    Table 46. Sarepta Therapeutics Basic Information List
    Table 47. Sarepta Therapeutics Description and Business Overview
    Table 48. Sarepta Therapeutics Gene Therapy Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Gene Therapy Business of Sarepta Therapeutics (2019-2024)
    Table 50. Sarepta Therapeutics Recent Developments
    Table 51. Alnylam Pharmaceuticals Basic Information List
    Table 52. Alnylam Pharmaceuticals Description and Business Overview
    Table 53. Alnylam Pharmaceuticals Gene Therapy Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Gene Therapy Business of Alnylam Pharmaceuticals (2019-2024)
    Table 55. Alnylam Pharmaceuticals Recent Developments
    Table 56. Amgen Basic Information List
    Table 57. Amgen Description and Business Overview
    Table 58. Amgen Gene Therapy Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Gene Therapy Business of Amgen (2019-2024)
    Table 60. Amgen Recent Developments
    Table 61. Spark Therapeutics Basic Information List
    Table 62. Spark Therapeutics Description and Business Overview
    Table 63. Spark Therapeutics Gene Therapy Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Gene Therapy Business of Spark Therapeutics (2019-2024)
    Table 65. Spark Therapeutics Recent Developments
    Table 66. Akcea Therapeutics Basic Information List
    Table 67. Akcea Therapeutics Description and Business Overview
    Table 68. Akcea Therapeutics Gene Therapy Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Gene Therapy Business of Akcea Therapeutics (2019-2024)
    Table 70. Akcea Therapeutics Recent Developments
    Table 71. bluebird bio Basic Information List
    Table 72. bluebird bio Description and Business Overview
    Table 73. bluebird bio Gene Therapy Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Gene Therapy Business of bluebird bio (2019-2024)
    Table 75. bluebird bio Recent Developments
    Table 76. Sunway Biotech Basic Information List
    Table 77. Sunway Biotech Description and Business Overview
    Table 78. Sunway Biotech Gene Therapy Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Gene Therapy Business of Sunway Biotech (2019-2024)
    Table 80. Sunway Biotech Recent Developments
    Table 81. SIBIONO Basic Information List
    Table 82. SIBIONO Description and Business Overview
    Table 83. SIBIONO Gene Therapy Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Gene Therapy Business of SIBIONO (2019-2024)
    Table 85. SIBIONO Recent Developments
    Table 86. AnGes Basic Information List
    Table 87. AnGes Description and Business Overview
    Table 88. AnGes Gene Therapy Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Gene Therapy Business of AnGes (2019-2024)
    Table 90. AnGes Recent Developments
    Table 91. Orchard Therapeutics Basic Information List
    Table 92. Orchard Therapeutics Description and Business Overview
    Table 93. Orchard Therapeutics Gene Therapy Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Gene Therapy Business of Orchard Therapeutics (2019-2024)
    Table 95. Orchard Therapeutics Recent Developments
    Table 96. Human Stem Cells Institute Basic Information List
    Table 97. Human Stem Cells Institute Description and Business Overview
    Table 98. Human Stem Cells Institute Gene Therapy Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Gene Therapy Business of Human Stem Cells Institute (2019-2024)
    Table 100. Human Stem Cells Institute Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Gene Therapy Downstream Customers
    Table 104. Gene Therapy Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Gene Therapy Product Picture
    Figure 2. Global Gene Therapy Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Gene Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 4. Gene Therapy Report Years Considered
    Figure 5. Global Gene Therapy Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Gene Therapy Revenue in 2023
    Figure 7. Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Viral Gene Therapy Picture
    Figure 9. Non-Viral Gene Therapy Picture
    Figure 10. Global Gene Therapy Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Gene Therapy Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Neurological Diseases
    Figure 13. Product Picture of Cancer
    Figure 14. Product Picture of Other
    Figure 15. Global Gene Therapy Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Gene Therapy Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Gene Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Gene Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Gene Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Gene Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Gene Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Gene Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Gene Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Gene Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Gene Therapy Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Gene Therapy Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Gene Therapy Sales Value (%), (2019-2030)
    Figure 28. United States Gene Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Gene Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Gene Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Gene Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Gene Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Gene Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Gene Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Gene Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Gene Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Gene Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Gene Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Gene Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Gene Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Gene Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Gene Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Gene Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Gene Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Gene Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Gene Therapy Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Gene Therapy Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Gene Therapy Sales Value by Application (%), 2023 VS 2030
    Figure 49. Gene Therapy Industrial Chain
    Figure 50. Gene Therapy Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Hemophilia Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3J6348
Fri May 17 00:00:00 UTC 2024

Add to Cart

Global Sickle Cell Disease Diagnosis and Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-18M13082
Tue May 14 00:00:00 UTC 2024

Add to Cart

Global Morquio Syndrome Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34H5635
Fri May 10 00:00:00 UTC 2024

Add to Cart

Global Leigh Syndrome Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35Y5644
Fri May 10 00:00:00 UTC 2024

Add to Cart